Page last updated: 2024-08-20

yohimbine and Acute Kidney Failure

yohimbine has been researched along with Acute Kidney Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Hayashi, K; Shimokawa, T; Tomita, S; Yamagata, M; Yoneda, K1
Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yukimura, T1
Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Tanba, T; Terada, T; Tojo, A; Tsutsui, H; Yamagata, M; Yoshida, S; Yukimura, T1
Aronson, P; Sandler, B1
Braunstein, G; Coody, GL; Favreau, JT; Fong, TL; Love, LA; Orshansky, G; Park, SS; Ryu, ML1

Other Studies

6 other study(ies) available for yohimbine and Acute Kidney Failure

ArticleYear
Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats.
    European journal of pharmacology, 2020, Mar-15, Volume: 871

    Topics: Active Transport, Cell Nucleus; Acute Kidney Injury; Animals; Cell Nucleus; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Enzymologic; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase Type II; Phosphorylation; Rats; Rats, Sprague-Dawley; Yohimbine

2020
Inhibition of α2C-adrenoceptors ameliorates cisplatin-induced acute renal failure in rats.
    European journal of pharmacology, 2018, Nov-05, Volume: 838

    Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Chemokine CCL2; Cisplatin; Disease Models, Animal; Injections, Intraperitoneal; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tumor Necrosis Factor-alpha; Yohimbine

2018
Renoprotective effect of yohimbine on ischaemia/reperfusion-induced acute kidney injury through α2C-adrenoceptors in rats.
    European journal of pharmacology, 2016, Jun-15, Volume: 781

    Topics: Acridines; Acute Kidney Injury; Adrenergic alpha-2 Receptor Antagonists; Animals; Chemokine CCL2; Cytoprotection; Gene Expression Regulation; Kidney; Male; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Reperfusion Injury; Tumor Necrosis Factor-alpha; Yohimbine

2016
Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome.
    Urology, 1993, Volume: 41, Issue:4

    Topics: Acute Kidney Injury; Adult; Drug Eruptions; Erectile Dysfunction; Humans; Lupus Erythematosus, Systemic; Male; Yohimbine

1993
Severe hepatotoxicity associated with the dietary supplement LipoKinetix.
    Annals of internal medicine, 2002, Apr-16, Volume: 136, Issue:8

    Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffeine; Chemical and Drug Induced Liver Injury; Dietary Supplements; Diiodothyronines; Drug Approval; Drug Combinations; Female; Humans; Male; Phenylpropanolamine; United States; United States Food and Drug Administration; Yohimbine

2002
Summary for patients. Liver failure associated with the dietary supplement LipoKinetix.
    Annals of internal medicine, 2002, Apr-16, Volume: 136, Issue:8

    Topics: Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Benzofurans; Benzopyrans; Caffeine; Chemical and Drug Induced Liver Injury; Dietary Supplements; Diiodothyronines; Drug Approval; Drug Combinations; Female; Humans; Male; Phenylpropanolamine; United States; United States Food and Drug Administration; Yohimbine

2002